Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Pharmaceuticals:

Facebook Twitter LinkedIn Email Comments
Photonics Prevents Recalls

Herbert Kaplan

The 1990s have marked a decade of significant change for quality control in the pharmaceutical industry. New governmental regulations in the US have prompted capital expenditures for automated inspection equipment that is increasingly replacing human inspectors -- and doing so more accurately.
In 1992, the average pharmaceutical recall cost $1.5 million for lost sales, production, disposal and notification. A year later, the FDA published new regulations about labeling and inspection. The regulations allowed continued use of human inspectors, but they indicated a strong preference for automated inspection, such as machine vision systems.

Photonics Spectra
Aug 1997
Features

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to Photonics Spectra magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.